<--- Back to Details
First PageDocument Content
Ethics / Medical ethics / Drug safety / Design of experiments / Pharmacology / Institutional review board / Division of Acquired Immunodeficiency Syndrome / Informed consent / Investigational New Drug / Clinical research / Research / Health
Date: 2013-07-12 14:09:13
Ethics
Medical ethics
Drug safety
Design of experiments
Pharmacology
Institutional review board
Division of Acquired Immunodeficiency Syndrome
Informed consent
Investigational New Drug
Clinical research
Research
Health

Policy: Requirements for Informed Consent Development

Add to Reading List

Source URL: www.niaid.nih.gov

Download Document from Source Website

File Size: 124,69 KB

Share Document on Facebook

Similar Documents

Client Disclosure and Informed Consent

DocID: 1vnrO - View Document

INFORMED CONSENT/PERMISSION FORM FOR EDUCATION TRIPS (Students Under 18 Years ) The Nipissing-Parry Sound Catholic District School Board is arranging a Summer School Physical Education Ice Hockey program Juy 2nd – July

DocID: 1vn2S - View Document

Gewebebank Bern Tel. Voranmeldung auf 23228  Informed Consent vorhanden  Chirurg....................................... Sucher........................................ Zeit (clamping)..........................

DocID: 1vj1g - View Document

INFORMED CONSENT ASSESSMENT FORM URERB Protocol Code: (to be filled out by URERB Secretariat)

DocID: 1vj0w - View Document

Informed Consent Form Checklist (Including Phase 1 Study) This checklist is designed to assist researchers in drafting, and CREC members in reviewing Informed Consent Forms (including Phase 1 Study). The checklist conta

DocID: 1v8vO - View Document